Product Overview

Developing therapies for Singaporean NASH will require understanding the genetic and biological drivers of its progression from NAFL.

We are building a cohort for this purpose and are inviting partners to join.

SingaporeanNASH_blurry

 



Other Available Disease Cohorts

View All Our Cohorts
  • Oncology
  • Liver Disease
  • Cardiovascular
  • Neurology & Pain
  • Immunology & Rheumatology
  • Diabetes & Complications
  • Respiratory
  • Ophthalmology
  • Dermatology